AI Science Tracker

Novo Nordisk A/S

1 discovery from 2022

Discoveries

Novo Nordisk A/S

Mass spectrometry and machine learning identify bioactive peptide NHPD-50

A predicted-peptide-variant model trained using mass-spectrometry observations from seven mouse tissues helped prioritize candidate peptides. The authors report that NHPD-50, a secretogranin-1-derived peptide, lowered blood glucose and increased plasma insulin in specified diabetic-mouse experiments. The authors state that the data do not establish the peptide’s exact mechanism. These are early preclinical findings, not a human diabetes treatment; other predicted peptides had different or absent outcomes.

Technology: Predicted-peptide-variant machine-learning prioritization from mass-spectrometry data

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Primary paper reports the stated mouse assay results.
  • Still unknown: Independent replication and exhaustive prior-art review are not established; the paper states that the mechanism is undetermined.
  • AI role: A predicted-peptide-variant model prioritized candidate sequences from mass-spectrometry data; biological activity was established through subsequent assays.

Evidence sources: https://www.nature.com/articles/s41467-022-34031-z

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 16 Nov 2026. Review scope: Primary Nature full article and bibliographic metadata reviewed for identity, AI role, date, affiliation and bounded mouse results..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.